Template:Implantable Cardioverter Defibrillator ACC/AHA/HRS Guidelines: Difference between revisions
Jump to navigation
Jump to search
Dima Nimri (talk | contribs) No edit summary |
Dima Nimri (talk | contribs) No edit summary |
||
| Line 6: | Line 6: | ||
! | ! | ||
|- | |- | ||
| colspan="1" style="text-align:center; background:LightCoral" | | | colspan="1" style="text-align:center; background:LightCoral" | '''Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities''' | ||
Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities | |||
|- | |- | ||
! | ! | ||
| Line 26: | Line 23: | ||
|- | |- | ||
| colspan="1" style="text-align:center; background: | | colspan="1" style="text-align:center; background:CornFlowerBlue" | '''Expert Consensus on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials''' | ||
Expert Consensus on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials | |||
|- | |- | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ICD in the context of abnormal troponin|ICD Implantation in the Context of an Abnormal Troponin that is Not Due to a Myocardial Infarction]] | [[ICD in the context of abnormal troponin|ICD Implantation in the Context of an Abnormal Troponin that is Not Due to a Myocardial Infarction]] | ||
| Line 39: | Line 33: | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ICD implantation within 40 days of myocardial infarction|ICD Implantation Within 40 Days of a Myocardial Infarction]] | [[ICD implantation within 40 days of myocardial infarction|ICD Implantation Within 40 Days of a Myocardial Infarction]] | ||
| Line 45: | Line 39: | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ICD within 90 days of revascularization|ICD Implantation Within 90 Days of Revascularization]] | [[ICD within 90 days of revascularization|ICD Implantation Within 90 Days of Revascularization]] | ||
| Line 51: | Line 45: | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ICD <9 months from diagnosis of nonischemic cardiomyopathy|ICD Implantation <9 Months From The Initial Diagnosis of Nonischemic Cardiomyopathy]] | [[ICD <9 months from diagnosis of nonischemic cardiomyopathy|ICD Implantation <9 Months From The Initial Diagnosis of Nonischemic Cardiomyopathy]] | ||
Revision as of 16:37, 26 October 2016
| Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities |
| Expert Consensus on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials |
|
ICD Implantation in the Context of an Abnormal Troponin that is Not Due to a Myocardial Infarction |
|
[[ICD <9 months from diagnosis of nonischemic cardiomyopathy|ICD Implantation <9 Months From The Initial Diagnosis of Nonischemic Cardiomyopathy]] |